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Proper neural function relies on the regulation of the diversity and the 
proportion of neuronal and non-neuronal cell types. Glia, non-neuronal neural cells, 
have emerged as key players in the development, function, and maintenance of the 
central nervous system (CNS). Glia constitute as much as 50% of the cellular population 
in the CNS. As our understanding of the array of glial functions increases, little is 
understood about the physiological basis and developmental origin of glial abundance 
and diversity. 
`  
The mammalian neocortex is a highly organized structure that plays a crucial 
role in higher-order brain functions such as cognition and integrating sensory input. 
Radial glial progenitors (RGPs) that line the cerebral ventricles and are positive for the 
transcription factor Emx1 produce neocortical excitatory neurons and glia in a 
sequential manner. Previous lineage tracing has revealed that at the conclusion of 
neurogenesis 16% of RGPs proceed to gliogenesis. During development, these RGPs 
 	
	
generate discrete columnar structures that contain neurons, astrocytes, and 
oligodendrocytes. To understand how the diversification of glia is mediated by 
individual progenitors, we performed clonal analysis of neocortical RGPs at their 
transition from neurogenesis to gliogenesis using Mosaic Analysis with Double Markers 
(MADM).  
 
In terms of lineage specification, our analysis uncovered three distinct types of 
gliogenic RGPs based on their potential to generate neural cell types. The proportion 
RGP subtypes is independent of time of exit from neurogenesis and location along the 
anterior-posterior axis. Quantitatively, MADM-based clonal analysis of neocortical 
gliogenesis revealed that the number of glia produced by an individual RGP is 
independent from the time exit from neurogenesis occurs. Our analysis shows that the 
overall ratio of Emx1-derived glia to neurons is 1:5. Our analysis suggests that although 
the majority of neocortical astrocytes are Emx1-RGP derived, a significant proportion of 
oligodendroglia are derived from other origins. We also found that different programs 
regulate the proliferation of astrocyte-restricted and oligodendrocyte-restricted glial 
precursors, with oligodendrocyte precursors having a larger proliferative capacity 
compared to astrocyte precursors. In terms of distribution and structure, analysis of the 
laminar distribution of astrocyte clones suggests separate lineages for Layer-1 and 
 	
	
white matter (WM) astrocytes and that astrogliogenesis, similar to neurogenesis, 
proceeds in an inside-out fashion. Most oligodendrocyte clones are clustered into a 
single layer and the majority of RGP-derived oligodendrocytes are destined for deep 
cortical layers, whereas RGP-derived astrocytes are more evenly spread through the 
cortical width. Our results reveal how the production of neuronal and non-neuronal cell 
types are developmentally regulated in individual progenitors. In particular, shedding 
insight on the regulation of lineage specification of glial types, establishment of 
neuron:glia ratio, and the distribution and structure of RGP-derived glia in the 
neocortex. 
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Chapter 1 
 
Introduction to gliogenesis in the neocortex  
 
1.1 Neural cells of the cerebral cortex. 
Proper neural function requires the generation of diverse neuronal and glial cell 
types in correct proportions. Glia is a term that refers to the non-neuronal cells of the 
nervous system and comprises several cell types including microglia, ependymal cells, 
astrocytes, and oligodendrocytes in the central nervous system (CNS); and Schwann 
cells and satellite cells in the peripheral nervous system (PNS). Classically considered a 
homogenous passive population that has a mere support role, glia are increasingly 
recognized to be key players in neural development, function, and maintenance. Glia 
play many roles which include supplying nutrients to neurons, and providing 
structural support to neural tissue; they insulate and repair axons, clear the extracellular 
environment of pathogens and dead neurons, and regulate synaptogenesis and synaptic 
transmission. Despite the wide array of functions assigned to glia, and the fact that they 
constitute about 50% of the cellular population in the brain1,2, our understanding of glia 
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function, physiology, and development has greatly lagged behind that of their neuronal 
counterparts.  
 
The physiological basis and developmental origin of glial abundance and 
heterogeneity persists as an open question. Although there is evidence for 
physiological, morphological, and molecular diversity in glial populations, the origins 
and functional implications of this heterogeneity are poorly understood, in great part 
due to the lack of tools to study specific astrocyte subpopulations. A deeper 
understanding of glial development may reveal novel cell fate determinants for glia and 
provide tools for the manipulation of specific subpopulations. This will allow a deeper 
interrogation of glial contribution during development, how they maintain proper brain 
function, how they malfunction in disease, and how they repair tissue. In addition, 
because glia retain their capacity to proliferate and differentiate during adulthood, 
novel therapies may be developed that take advantage of glial developmental and 
repair processes to regenerate neural cells and tissue.  
 
A significant hindrance to the study of glial function and properties has been the 
lack of tools to specifically target glial progenitors and glial subpopulations. We 
circumvent this limitation by focusing our study of gliogenesis on a specific neural 
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progenitor cell (NPC) population, the radial glia progenitor (RGP) of the telencephalic 
dorsal ventricular zone which produces excitatory neurons and glia of the neocortex in 
a sequential manner. Through the study of a common precursor of neurons and glia, we 
venture to explore the impact of developmental origin in the assembly of the neural 
population of the neocortex. Our work reveals how the proper number of neural cells, 
subtypes, and their distribution are regulated by individual RGPs   
 
The balance between the number of neuronal and non-neuronal cells is 
evolutionarily constrained suggesting a close link between neurogenesis and 
gliogenesis. Although the neuron-glia ratio varies across species, brain regions, and 
possibly disease contexts, the scaling rules that describe the relationship between 
neurons and glia vary uniformly with neuronal density across mammalian species 
spanning 90 years of evolution1. This evolutionary constraint suggests a regulation of 
the mechanisms controlling glial development. This leads us to hypothesize that 
neurogenesis and gliogenesis are tightly coupled at the single progenitor cell level. To 
test this hypothesis, I aim to systematically analyze the potential of individual 
progenitors in generating neurons and glial cells. Our data reveals previously unknown 
mechanisms for specification of different neural cell types from common progenitors in 
vivo.  
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1.2 Neocortical glial subtypes 
The following subsections are an overview of the macroglia of the neocortex – 
astrocytes and oligodendrocytes. We focus our study on these glial cell types since they 
are derived from a common RGP progenitor along with neurons. Although microglia 
are the other prominent glial population in brain, they are not the topic of this study. 
Microglia do not originate from the neuroepithelium, as do the other neural cell types; 
but originate in the yolk sac, invading the neuroepithelium of the developing brain 
around E9.5, prior to the establishment of the blood-brain barrier3. 
 
1.2.1 Astrocytes and their functional diversity 
Astrocytes are stellate cells that branch into numerous processes that are in intimate 
association with surrounding synapses and vasculature. Astrocytes are thus positioned 
to be active participants in neural processes such as lactate metabolic coupling4, 
regulation of cerebral blood flow5, and synapse formation6 and synaptic transmission7–9.  
 
The close association of astrocytes to both pre- and post-synaptic components of 
neurotransmission has led to the coining of the term “tripartite synapse” to refer to the 
integration of these three elements in the modulation of synaptic transmission10. 
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Astrocytes regulate levels of neurotransmission through the clearing of 
neurotransmitters from the synaptic cleft. Although their ability to modulate synaptic 
transmission through the release of “gliotransmitters” remains controversial, astrocytes 
express diverse types of receptors for different neurotransmitters. Following an increase 
of intracellular calcium, astrocytes release gliotransmitters such as glutamate11, ATP12, 
and D-Serine13,14. Astrocytes are homogenously distributed within the grey matter 
occupying non-overlapping territories so that the neuronal parenchyma is divided into 
territories of similar volumes termed “synaptic islands” where an estimated 100,000 
synapses are under the regulation of a hippocampal astrocyte, and 600-800 under the 
regulation of a neocortical astrocyte15,16. Astrocytes may also communicate extensively 
with each other via gap junction-mediated calcium signaling17. Normal astrocytic 
activity is important for cognitive function. For instance, astrocytic activity and Ca2+ 
signaling are necessary for motor learning18. Astrocyte dysfunction has been implicated 
in conditions such as schizophrenia, autism spectrum disorder (ASD), and Fragile X 
syndrome19–21.  
 
Astrocytes are key mediators of neurovascular coupling. Cerebral blood flow is 
modulated in response to neural activity to meet the metabolic needs of neurons in a 
process termed functional hyperemia22. This provides neurons increased levels of 
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oxygen and glucose while helping clear excess metabolites and neurotransmitters from 
the extracellular space. Neurons rarely make direct contact with the vasculature, relying 
instead on astrocytes as intermediaries for communication with the cerebral 
vasculature. Electron microscopy shows perivascular processes of astrocytes completely 
ensheath the endothelial cells in the blood vessels of the cerebral microvasculature; 
astrocyte endfeet interdigitate extensively at vascular endfoot-endfoot contacts, with 
little discontinuity between23. Most protoplasmic astrocytes extend at least one 
perivascular endfoot. A specialized subtype of astrocyte, the perivascular astrocyte, has 
been described which has its soma in direct contact with the cerebral vasculature. 
Clonal analysis of cortical astrocytes after in utero electroporation at E14 using the Star 
Track approach, which relies on the stochastic expression of 12 different fluorescent 
reporters under the control of the hGFAP promoter, revealed clones composed of up to 
40 perivascular astrocytes distributed radially along a single blood vessel24. This 
suggests that perivascular astrocytes in the cortex are derived from a common 
progenitor. Perivascular astrocytes have been observed to preferentially proliferate 
compared to surrounding protoplasmic (gray matter) astrocytes in response to cortical 
injury– a response that is clone-specific25,26.  
 
1.2.2 Neocortical astrocyte heterogeneity 
  
 
	7	
Little is known about whether astrocytes encode heterogeneous signals involved 
in neuronal circuit formation and/or maintenance. There is a clear morphological 
distinction between astrocytes in different brain regions27. Molecularly, single-cell RNA-
sequencing (sc-RNAseq) revealed seven subclasses of astrocytes with distinct regional 
allocations. These subtypes differ in the expression of several genes including 
neurotransmitter transporters such as GAT3 (GABA transporter type 3) and GLYT1 
(glycine transporter 1), which may confer distinct physiological properties between 
subtypes. Astrocyte subpopulations throughout the brain could be further subdivided 
based on GFAP expression (high versus low). Astrocytes from the two pools of GFAP-
expression are molecularly similar, suggesting GFAP expression is a source of 
variability independent from the previously mentioned seven subclasses identified by 
scRNAseq 28. Although there is increasing data on interregional differences between 
astrocytes, there is limited evidence of heterogeneity among astrocytes dispersed in the 
same region, particularly in terms of function and molecular expression. In the 
telencephalon, two subtypes of astrocytes were identified by sc-RNAseq which differ in 
the expression of several genes28. Heterogeneity in Gli-1 (Zinc finger protein GL1, 
glioma-associated oncogene) expression has been described in cortical astrocytes29; in 
the human brain, a subpopulation of astrocytes expresses the cell adhesion molecule 
CD4430; in the hippocampus, Kir4.1(KCNJ10/ATP-sensitive inward rectifier potassium 
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channel 10) expression differs among the astrocyte population, resulting in 
heterogeneity in hippocampal astrocyte physiological properties31.  
 
The current established astrocyte subtypes of the mammalian neocortex are 
distinguished by morphological and location criteria. They also differ in the amount of 
GFAP detectible by immunohistochemistry. In the murine brain, these subtypes are: (1) 
protoplasmic astrocytes – this cell type has a stellate morphology with 5-6 main 
branches radiating from the cell soma and branches into smaller ramifications, granting 
them a “bushy” appearance. Protoplasmic astrocytes are distributed throughout the 
gray matter. (2) Fibrous astrocytes – characterized by their localization in the white 
matter, have thick branching processes with a higher expression level of the 
intermediate filament glial fibrillary acidic protein (GFAP) than protoplasmic 
astrocytes32. (3) There are specialized astrocytes in layer I of the neocortex which cover 
the surface just under the pia mater, forming the glial limiting membrane or glia 
limitans. Evidence suggests that layer 1 astrocytes may have a different developmental 
origin than the two aforementioned subtypes. They are characterized by having a 
“fibroblast-like” morphology and high expression of GFAP24,26.  Two additional 
astrocyte subtypes are exclusive to primate brains: (4) interlaminar astrocytes, whose 
cells bodies reside in Layer 1 and extend straight processes terminating in blood vessels 
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in layers 2-433. (5) The second primate-exclusive astrocyte subtype are the varicose 
projection astrocytes which are situated mainly in layers 5 and 6 and extend one to five 
processes up to 1 mM long which may terminate in the vasculature or neuropil34. 
 
   
1.2.3 Overview of oligodendrocytes and NG2-cells 
Oligodendrocytes are responsible for the myelination of axons, providing the 
physical and physiological insulation that allows for the saltatory conduction of signals 
along axons: Myelinated segments lack voltage-gated ion channels, preventing the loss 
of electrical signal along the axon. Unmyelinated segments, termed nodes of Ranvier, 
are enriched for voltage-gated sodium channels. Current generated by an action 
potential travels from one node of Ranvier through myelinated segments, where myelin 
prevents current from leaking across the internodal membrane. When the current 
reaches the node of Ranvier in the next segment, voltage-gated channels open and 
regenerate the action potential. Action potentials therefore jump from one 
unmyelinated segment to the next, hence the term “saltatory” conduction. Saltatory 
conduction accelerates the velocity at which electrical signal travels the axons. 
Myelinated axons can conduct to velocities up to 150m/s, compared to 0.5-10 m/s for 
unmyelinated axons35. CNS oligodendrocytes form myelin sheaths on multiple axons, 
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up to 30, so that sequential myelinated segments on an axon are derived from different 
oligodendrocytes. Myelin is an extension of the plasma membrane of oligodendrocytes 
and has a composition high in lipids, including sphingomyelin and cholesterol. It’s also 
composed proteins such as myelin basic protein (MBP), myelin oligodendrocyte 
glycoprotein (MOG), and proteolipid protein (PLP) which provide myelin with 
structural integrity.  
  
Skill learning is associated with an increase in myelination in axonal tracts of 
relevant circuits. This proliferation may be mediated through increased neural activity 
as it has been demonstrated that stimulation of neurons promotes oligodendrogenesis 
and increases myelination in a circuit-specific manner36. The conductance of action 
potentials is modulated by the width of the myelin sheath and internodal distance. 
Although myelination is crucial to brain function and demyelination is a feature of 
many neurological diseases including multiple sclerosis (MS), the mechanisms for 
myelination and axon recognition by oligodendrocytes are not well understood. In 
addition to providing axonal insulation, oligodendrocytes also provide critical trophic 
and metabolic support to neurons37.  
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The adult CNS also contains an abundant population of oligodendrocyte precursor 
cells (OPCs). These cells, positive for the chondroitin-surface proteoglycan 4 
(cspg4/NG2) are termed NG2-cells, and their specialized functions beyond acting as 
OPCs have led to their recognition as the fourth major glial population in the CNS, 
distinct from oligodendrocytes, astrocytes, and microglia. Like astrocytes, these cells are 
distributed throughout the gray matter and maintain unique territories via self-
avoidance. Loss of an NG2-cell through death, differentiation to oligodendrocytes, or 
ablation, leads to the proliferation of adjacent cells. These cells also proliferate in 
response to injury to participate in tissue repair, or activity to mediate myelination. 
NG2-cells are distributed uniformly throughout different neocortical layers even 
though oligodendrocyte density is significantly higher in the deep layers. This suggests 
that many NG2 cells never differentiate into oligodendrocytes38. Despite being 
recognized as OPCs, NG2-cells also have the potential to generate astrocytes in the 
ventral forebrain during development, but not at adult stages39.  
 
1.2.4 Neocortical oligodendrocyte heterogeneity 
Oligodendrocytes have been considered a functionally homogenous population in 
the CNS. However, single-cell RNA sequencing revealed thirteen distinct populations 
of oligodendrocytes representing a continuum from Pdgfra+ OPCs to distinct mature 
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oligodendrocytes40. There is more evidence of functional heterogeneity in NG2 cells 
(OPCs). NG2-cells have heterogeneous differentiation potential – NG2 cells of the 
ventral, but not the dorsal, forebrain have the potential to generate astrocytes. These 
ventral NG2 glia generate gray matter (GM) (protoplasmic) but not WM (fibrous) 
astrocytes39,41. In the dorsal cortex, GM and WM NG2 cells differ in their 
electrophysiological properties42. In adult mice, GM NG2 cells mostly generate post-
mitotic NG2-cells, whereas WM NG2-cells generate mostly mature oligodendrocytes43. 
 
Current criteria for distinction between subtypes of oligodendrocytes would require 
sc-RNAseq or in situ hybridization to distinguish between different oligodendrocytes. 
Clonal analysis requires very sparse labeling of progenitors and the resulting daughter 
cells, so we are unable to combine this method with our MADM approach to examine 
how developmental origin may contribute to oligodendrocyte heterogeneity. In 
contrast, for astrocytes, we may use morphology and laminar location to identify their 
subtype. 
 
1.3 The Radial Unit Hypothesis 
The mammalian neocortex is a highly organized structure that plays a crucial role in 
higher-order brain functions such as cognition and integrating sensory input. The radial 
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unit hypothesis, postulated in 1988 by Pasko Rakic, suggests that the RGP-derived 
ontogenetic column is the basic building block of the cerebral cortex44,45. 
 
The hallmarks of neocortical structural and functional organization are lamination 
and radial organization. Evidence supports that the behavior of the RGP underlies the 
formation of this highly ordered structure. The neocortex is a six-layered structure, the 
boundaries of which can be readily distinguished by histological staining. Each layer 
has unique neuronal populations with distinct morphology, molecular composition, 
and afferents and projections, which links cytoarchitecture to function. These ordered 
laminae are formed through a concerted production and migration of neurons46. Thus, a 
single RGP progenitor proceeds to diversify the neuronal population of the cortex 
through sequential derivation of different subtypes through a common progenitor, and 
cell number is generated by a deterministic program where each progenitor generates 8-
9 neurons47.  
 
1.3.3 Sequential derivation of neural cell subtypes from a common RGP 
In the developing neocortex, neurons and three types of macroglia – astrocytes, 
NG2-cells, and oligodendrocytes, are derived from common multipotent NPCs. In the 
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neuroepithelial cells (NE). As development proceeds, around E9, a more fate-restricted 
progenitor is specified from the NE, the radial glial progenitor (RGP). RGPs reside in 
the transient ventricular zone (VZ) which lines the cerebral ventricles. RGPs are 
characterized by their bipolar morphology, with a short apical process which acts as an 
end foot anchorage to the VZ surface, and a basal process that extends to the pial 
surface. At early stages of neurogenesis, RGPs divide symmetrically to expand the 
progenitor pool, and then switch to asymmetric division where they self-renew and 
generate one daughter cell: either a post-mitotic neuron or an intermediate progenitor 
cell (IPC). IPCs may undergo one to two rounds of symmetric division in the 
subventricular zone (SVZ) to generate neurons. Generated neurons migrate along the 
radial glial fiber. Early-born neurons migrate to the nascent cortical plate; successive 
waves of neurons migrate past earlier born neurons occupying increasingly superficial 
layers48–56. At the conclusion of neurogenesis, around E16, RGPs proceeds to gliogenesis. 
It would be of interest to examine whether the similar processes that lead to the 
diversification of the neuronal population also contribute to generating the diverse glial 
subtypes of the neocortex. 
 
1.3.2 Role of RGP in the functional assembly of the neocortex 
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Functionally, the neocortex is organized into functional columns so that neurons 
sharing common properties, for instance receptive fields in somatosensation or 
orientation selectivity in vision, are distributed radially so that these properties are 
similar between neurons within a column but differ significantly among adjacent 
columns57.  
 
Lineage relationship plays an important role in the functional organization of the 
cortex. It has been suggested that the RGP-derived ontogenetic column is related to 
functional columns. Previous work has found that lineage-related sister neurons 
preferentially form chemical synapses with each other. This preferential coupling is in 
part mediated by preferential gap-junction coupling of sister cells58,59. To support this 
hypothesis, it has been demonstrated that sister excitatory neurons in layer 2/3 exhibit 
similar orientation tuning properties60. Because neurons and glia are derived from the 
same RGP pool, how does the lineage relationship influence the number, subtypes, and 
functional relationships of glia and neurons? 
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Figure 1.1. Diverse of origins of neocortical glia. (A) Various modes of astrogliogenesis 
and astrocyte subtypes. Image panels represent astrocyte generation during different 
developmental stages. Different modes of division are described in the following 
subsections: mode 1, section 1.6.1; mode 2, section 1.6.3; mode 3, section 1.6.2; mode 4, 
section 1.6.4; mode 5-8, section 1.6.5. E, embryonic day; P, postnatal day; GM, gray 
matter; WM, white matter; M, meninges or pia matter; PPL, primordial plexiform layer; 
VZ, ventricular zone; SVZ, subventricular zone; IZ, intermediate zone; CP, cortical 
plate; BV, blood vessel. Adapted from Tabata, 201561. (B) Three different waves of 
competing oligodendrocytes derived from different progenitor domains. Wave 1, from 
Nkx2.1-expressing progenitors in the MGE VZ starting at E12.5; wave 2, from Gsh2-
expressing progenitors in the LGE-CGE VZ starting at E15.5; wave 3, Emx1-expressing 
progenitors starting around birth. Adapted from Kessaris et. al 200662.  
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1.4 The neuron/glia switch in RGPs 
Temporal control of the switch from neurogenesis to gliogenesis is critical to 
producing numbers and subtypes of neural cells in correct proportions to sustain brain 
function. The mechanism controlling the transition from neurogenesis to gliogenesis in 
the vertebrate CNS is complex and not well understood. The gliogenic switch occurs 
around E12.5 in the spinal cord and E16 in the cortex. In the murine brain, RGPs are 
first exclusively GLAST+/Nestin+ and produce neurons preferentially (GLAST: 
glutamate aspartate transporter). A population of GLAST+/Nestin- RGPs emerges in the 
later stages, that preferentially produces astrocytes63. In rodents, RGPs are GFAP-
negative until the completion of neurogenesis, where the intermediate filament protein 
composition is switched from vimentin to GFAP45.  
 
Our understanding of glial development is hindered by the lack of markers to 
exclusively target glial-specific progenitors. Most current evidence for astroglial-specific 
transcription factors in mammals has come from studies in the developing spinal cord. 
NFIA (Nuclear factor 1 A-type) was found to be both necessary and sufficient for 
embryonic gliogenesis as well as astrogenesis64. Sox9 was also shown to regulate early 
gliogenesis through its regulation of NFIA induction and its association with NFIA 
during subsequent gliogenic stages65,66. NFIA is expressed in OPCs and antagonizes the 
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ability of Sox10 to induce myelin genes, with the level of NFIA being downregulated 
before myelin gene expression. Overexpression and knock-down experiments in vitro 
and in vivo suggest that Zbtb20, together with Sox9 and NFIA, promotes 
astrocytogenesis67.  
 
In our understanding of gliogenesis, the link between astrogliogenesis and 
oligodendrogenesis remains unclear. The existence Zbtb20+/Olig2+ cells that are 
negative for Sox10, a marker of OPCs, has been reported67. This suggests that cells 
expressing Olig2 may act as astrocyte precursors. It is unclear whether these Olig2+ 
astroglial progenitors have lost or will gain Sox10 expression to transition to or from 
oligodendrogenesis. At the population level, neocortical astrocytes are detected at 
earlier timepoints than oligodendrocytes.  
 
Astrogliogenesis begins towards the end of the neurogenic period and is regulated 
by cell-intrinsic programs as well as extrinsic signals that decrease neurogenic and 
increase astrogenic competence over developmental time. Intrinsic programs include 
epigenetic changes that lead to Polycomb-dependent suppression of proneural genes 
such as the neurogenins ngn1 and ngn268. Extrinsic signals include leukemia inhibitory 
factor (LIF), ciliary neurotrophic factor (CNTF), and cardiotrophin-1 (CT-1), which are 
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members of the interleukin-6 family of cytokines. Cytokine signaling activates the JAK-
STAT (Janus kinase – signal transducer and activator of transcription) pathway which 
promotes astrocyte differentiation69,70. In addition, bone morphogenic protein (BMP)-
Smad and Notch signaling pathways engage in cross-talk with the JAK-STAT pathway 
to promote astrocyte differentiation71. 
 
1.5 Three different competing waves of oligodendrocytes 
Oligodendrocytes of the telencephalon are generated in three temporally and 
spatially distinct waves: The first wave appears at E12.5 and originates from Nkx2.1+ 
progenitors in the medial ganglionic eminence (MGE). The second wave appears at 
E15.5, in the lateral ganglionic eminence (Gsh2+ progenitors). The third wave arises at 
P0 from the cerebral cortex (Emx1+ progenitors). OPCs derived from the first two waves 
migrate tangentially to populate the cortex, where cells from one wave are selectively 
lost and replaced by OPCs from the subsequent waves62. The mechanisms for this 
oligodendrocyte loss are unknown. Death may be due to the competition for survival 
signal from axons72 but how oligodendrocytes from one particular domain selectively 
pruned is not yet understood (Figure 1.1B).  
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In the neocortex, NG2 cells from the last two cohorts (Gsh2, Emx1) are intermingled 
creating a mosaic population in respect to domain of origin. OPCs reach peak density 
during the first postnatal week, after which their density declines and their processes 
become less overlapping but begin to occupy defined domains throughout the entire 
parenchyma. At early postnatal stages, the contribution of cortical OPCs is about 30% 
from Gsh2 and 70% from Emx1. However, the latter population drops to 30% as 
postnatal development proceeds62. 
 
Although distinct origins may lead to NG2 subtype heterogeneity, evidence 
suggests that cells derived from different domains are equivalent/similar or at least 
plastic enough to replace each other: direct ablation of NG2-cells generated during one 
of the waves could be completely compensated by cells originating from the other 
neural precursors62. 
 
The relative contribution of radial glia and SVZ progenitors to NG2 
cell/oligodendrocyte production is not well established. It is also not known whether 
and how the astrogliogenesis program is suppressed when NG2 cells are generated or 
whether all progenitor cells in the pallium are equivalent in their ability to produce both 
astrocytes and NG2-cells after neurogenesis has been completed. 
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1.6 Diverse origins of cortical astrocytes  
During CNS development, neurogenesis precedes gliogenesis, with radial glia 
serving as both the scaffolding and the neural stem cell (NSC) for both cell types. 
During the first three weeks of postnatal development, the glial cell population expands 
6-8-fold in the rodent brain73. However, during early postnatal stages, radial glial cells 
lose their basal processes after they exit neurogenesis. This suggests different 
mechanisms generating the second wave of astrocytes (Figure 1.1A). There have been 
five routes of astrogenesis described.: 
 
1.6.1 Dividing RGP in the VZ:  
Lineage tracing studies in the spinal cord (SC) suggest that mature astrocyte 
populations are “tethered” to their VZ site of origin, suggesting limited migration 
during development74. Glia may be derived directly from a dividing RGP or be 
produced via an astrocyte-restricted precursor. Although studies have demonstrated 
the existence of astrocyte and glia-specific precursors75, specific markers for these cells 
remain largely uncharacterized. 
 
1.6.2 Transformation of RGPs: 
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The telencephalic RGPs are transient, and disappear or transform into astrocytes 
with the completion of cortical development. The differentiation of transforming RG to 
astrocytes has been directly shown by live-imaging54. RGP apical process retracts and 
RGP becomes multipolar in morphology resembling an astrocyte.  However, direct 
transformation of RG may only produce a limited number of astrocytes. Most radial glia 
have finished producing their share of astrocytes and have begun to disappear shortly 
after birth.  
 
1.6.3 Intermediate Glial Progenitors in SVZ: 
Classic lineage tracing experiments have established that astrocytes, in great part, 
derive from progenitors at the SVZ at early postnatal stages. SVZ progenitors and the 
production of astrocytes from proliferative glial progenitors in the SVZ almost ends by 
P1476.  
 
1.6.4 Marginal zone/L1 astrocyte precursors:  
In an early wave of astrocyte production, around the stage when the pre-plate 
forms, a subset of VZ-derived cells move on to the basal lamina underlining the pia 
mater and differentiate into Layer-1 astrocytes and form the subpial glia limiting 
membrane. As development proceeds, astrocytes, likely derived from the SVZ, migrate 
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into layer 1 to join the earlier generated astrocytes. It is not clear whether these different 
origins correspond to different subtypes of astrocytes, namely the fibroblast-like and 
protoplasmic astrocytes, since both reside in layer 1. In support of this hypothesis, 
clones of protoplasmic and clones of fibroblast-like astrocytes in Layer-I appeared to be 
exclusive of each other24, as demonstrated by lineage tracing using the technique 
StarTrak. Star Trak relies on the combinatorial expression of 12 distinct fluorescent 
proteins under the regulation of the hGFAP promoter. Marginal zone/L1 progenitors 
are not exclusive to making L1 astrocytes: it has been reported that a subset of 
protoplasmic astrocytes arises from Layer-I astrocytes or multipotent progenitors in 
layer-I of the cerebral cortex, so protoplasmic astrocytes may be derived from layer 1 
progenitors, not just progenitors in the SVZ.32,77.  
 
1.6.5 Local proliferation of differentiated astrocytes:  
Local generation of astrocytes within the postnatal cortex is thought to be a major 
source of glia, at least in layers I-IV, whereas astrocytes early in development are 
derived from radial glia and SVZ progenitors. While electroporation of P0-2 pups 
showed that only 3% of astrocytes derived postnatally from SVZ progenitors reached 
layer I-IV, local low titer retrovirus injections in superficial cortical layers at P0-2 and 
analysis 7-10 days later showed that as much as 50% of astrocytes had been generated 
  
 
	24	
from local divisions. Symmetric division of differentiated astrocytes was confirmed by 
two-photon imaging.78 This finding has led to the notion that astrocyte population 
expansion is based on ‘pioneer’ astrocytes – astrocytes derived from VZ/SVZ can 
migrate to colonize layers and then proliferate by local division. 
 
1.6 Previous in vivo lineage tracing of neocortical neural progenitors in vivo 
Genetic tracing methods of progenitors have also found a developmental 
relationship between neurons and glia. Neural progenitors in the neocortex generate 
discrete columnar structures that contain both projection neurons and protoplasmic 
astrocytes. Using a Thy1.2 Cre mouse line in which a random sparse subset of neural 
progenitors undergoes CRE/lox recombination, the astrocyte to neuron ratio of labeled 
cells in a labeled column was 1:7.4, similar to the overall ratio of 1:8.4 across the entire 
gray matter of the neocortex. This indicates that column-associated astrocytes account 
for the majority of astrocytes in the neocortex. Dividing cells were found at the base of 
neuronal columns at the beginning of gliogenesis and later within cortical layers, 
suggesting an inside-out mechanism by which astrocytes could be distributed within a 
column79. Previous lineage tracing in our lab using the MADM (mosaic analysis with 
double markers) method found that a similar fraction of clones produce neurons and 
glia throughout neurogenesis, suggesting that there is no glia-restricted poo of RGPsl. 
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In addition, we found that a fraction of 1 in 6 RGPs proceed to gliogenesis. Astrocytes 
and neurons are allocated in radial alignment to restricted domains that can span 
several layers. This reveals a close spatial association between lineage-related neurons 
and glia47. 
 
In summary, as our knowledge of the importance and diversity of glial function 
increases, it is crucial to bridge the gap of our understanding of the developmental 
processes that lead to the generation of the proper number and variety of glial cells. 
Importantly, the relationship between origin and mature heterogeneity of glia is 
unclear. It is still unknown how astrocyte clones, composed of cells originating from the 
same progenitor, impact astrocyte heterogeneity and function. A significant hindrance 
to understanding the developmental basis of glial function and diversity is the lack of 
markers to selectively target progenitors of these cells types. Here, we carried out 
analyses of neocortical RGPs that give rise to neurons and glia in order to understand 
the developmental processes that lead to the diversification of glia at the individual 
progenitor levels.  
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Chapter 2 
Overview of Experimental Approach for clonal labeling of 
neocortical radial glial progenitors 
 
2.1 Lineage tracing and clonal analysis of progenitors 
Lineage tracing is a developmental biology approach where the origins and fates 
of tissues are interrogated by labeling single progenitors with an inheritable mark and 
analyzing their progeny. In clonal analysis, traced progenitors and the resulting clone of 
daughter cells are studied. This type of analysis reveals how individual progenitors are 
regulated to ensure the proper structural and functional assembly of tissues. In order to 
perform clonal analysis of glial progenitors in vivo, we took advantage of the MADM 
(Mosaic Analysis with Double Markers) system80,81. We chose MADM as a tracing 
method as it provides increased information about lineage history of clones. By labeling 
the two daughter lineages of a progenitor with distinct fluorescent proteins, MADM 
permits separate tracking of each daughter lineage, increasing our insight into the 
lineage history of clonally-related cells.  
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2.2 Lineage Tracing using Mosaic Analysis with Double Markers 
MADM is a method adapted from the system MARCM80, originally developed 
for the study of genetic mosaics in Drosophila melanogaster. Its use for mosaic analysis is 
based on its ability to uniquely label homozygous mutant cells in an otherwise 
heterozygous background. MADM relies on two chimeric constructs composed of 
reciprocal halves of functional fluorescent proteins separated by a loxP site. These 
constructs are knocked-in to homologous sites on sister chromatids (Figure 2.1A). One 
MADM allele contains the N-terminus of GFP separated by a loxP site from the the C-
terminus of RFP (we refer to this allele as GT). The other MADM allele contains the N-
terminus of RFP with the C-terminus of GFP separated by a loxP site (hereafter referred 
to as TG). After DNA replication in animals heterozygous for the GT and TG alleles, 
Cre-recombinase, supplied as a separate transgene, mediates inter-chromosomal 
recombination restoring two functional fluorescent protein cassettes. Upon mitosis, 
different routes of chromosomal segregation yield two different outcomes in daughter 
cell labeling: 1) In G2-X segregation, chromatids encoding fluorescent proteins are 
segregated into different daughter cells. This results in a daughter lineage permanently 
labeled red and the other lineage permanently labeled green. 2) In G2-Z segregation, 
both chromatids encoding functional fluorescent proteins are segregated to the same 
daughter cell, while the other daughter cell inherits the two non-functional alleles. This 
  
 
	28	
results in a daughter lineage permanently labeled yellow and while other daughter 
lineage remains unlabeled. It is also possible for interchromosomal recombination to 
occur in post-mitotic cells at G0 or G1, which results in an individual cell labeled 
yellow. In 2010, a version of MADM was made available where GT/TG alleles where 
knocked-in to the Hip11 locus of chromosome 11 and original MADM RFP, dsRed2, 
was replaced by tdTomato82. 
 
Through the supply of a cell type-specific, inducible Cre recombinase, MADM 
allows clonal analysis in a temporal- and cell type-specific fashion. We take advantage 
of these properties to perform clonal analysis of neocortical radial glial progenitors 
(RGPs) which give rise to the neural cell types of the neocortex, namely, neurons, 
astrocytes, and oligodendrocytes.  
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Figure 2.1 Schematic of MADM-based labeling of daughter lineages of dividing 
progenitors. (A) Heterozygous alleles of MADM replicate in S-phase and are subject to 
Cre-mediated recombination, restoring functional fluorescent protein cassettes in two 
chromatids of the dividing progenitors. Allocation of alleles during mitosis results in 
singly or doubly-labeled daughter lineages. G0 or G1 recombination may restore two 
fluorescent proteins in a single cell.  Figure adapted from Gao et al. Cell, 201447. (B) 
Experimental paradigm of MADM-based clonal analysis. A single dose of TM is 
administered to pregnant females at E10, E11, E12, E13, E14, E15, or E16 and brains are 
analyzed at P21-P38, when cortical development is largely complete. E, embryonic day; 
P, postnatal day. 
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2.3 Approach to clonal analysis of neocortical gliogenesis 
The study of glial development has been obstructed by the lack of markers 
specific to glial progenitors. We circumvent this problem through the tracing of glial 
lineages derived from a specific subset of the glial progenitors in the forebrain, namely 
the RGPs of the dorsal telecephalon. In previous MADM-based clonal analysis 
performed in our lab, we recovered clones of neurons accompanied by glia derived 
from individual RGPs. By selectively targeting RGPs during late embryogenesis, we are 
to capture RGPs at their entry into gliogenesis and can use the recovered data to 
examine the relationships of clonally-related neurons, astrocytes, and oligodendrocytes. 
We target dorsal RGPs by supplying a CreERT2-recombinase driven by the Emx1 
promoter as a separate transgene. Emx1 is a transcription factor selectively expressed in 
dorsal progenitors. With Cre-ERT2, Cre is fused to the extracellular domain of the 
estrogen receptor. Upon availability of tamoxifen (TM), the ER domain releases the Cre 
which then is able to translocate to the nucleus and recognize the loxP sites. This allows 
cell-type and temporal specificity of Cre-mediated recombination.  
 
We administer TM via oral gavage or intraperitoneal injections to timed 
pregnant damns. We rescued the pups via C-section at E18/P0. We analyzed the brains 
of adult animals at P21-P38, when cortical development and astrogliogenesis are largely 
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concluded (Figure 2.1B). Tissue was serially sectioned into 70-100 µm sections. 100 µm 
sections resulted in us capturing more complete morphologies of cells in individual 
sections compared to 70 µm sections. We enhanced the intrinsic signal of the expressed 
GFP and RFP via immunohistochemistry, using antibodies specific to each fluorescent 
protein. The sections were mounted onto slides for analysis. Full brain scans were 
performed by either optical detection in an epifluorescent microscope or by scanning 
entire brains using a slide scanner. Once a clone with mixed green-red cells was 
identified, we traced the contours of either the entire mounted brain or selected sections 
corresponding to the clone and its flanking sections, with the software Neurolucida. We 
labeled positions of cell bodies and drew interlaminar borders based on DAPI signal. 
Information was recorded about cell identity, cell color, cell position, and neocortical 
region (Figure 2.2). To identify neocortical regions, we used landmarks such as the 
lateral ventricles and the hippocampus to match our contoured sections to annotated 
coronal sections of the adult mouse in the Allen Brain Atlas. For instance, the border 
between the motor cortex and the somatosensory cortex can be identified by finding the 
lateral border of layer 4.  
   
To recognize a group of cells as belonging to a clone, we used the criteria of 
isolation and clustering. A clone is identified as a clustered group of labeled cells 
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separate from any other labeled cells in the brain. In clonal analysis, it is crucial to 
minimize splitting or lumping errors in identifying clones, which may result from using 
spatial criteria to identify a clone. Splitting errors result in a single clone of cells 
identified as multiple clones due to spatial separation of lineage-related cells. Lumping 
errors result in non-clonally related cells detected as belonging to the same clone due to 
their proximity. Due to the small size of the clones we analyzed and because glia can 
undergo extensive migration (eg. OPCs derived from ventral progenitors domains 
migrate to populate the neocortex, see section 1.5), we want to minimize errors in clone 
detection. For these reasons, it was crucial we adjust the MADM labeling efficiency to 
limit the number of clones labeled in individual brains. Sparse labeling is intrinsic to the 
MADM system, as it requires interchromosomal recombination, a rare event80. To 
further limit the number of labeled progenitors per brain, we titrated our TM dosage 
until only a few clones were available in each brain. The low dose resulted in very 
sparse labeling, with several brains per litter devoid of MADM labeling, and others 
devoid of G2-X neuron/glia clones. For our brains analyzed at late embryonic inductions 
the average was 2.4 clones per brain for 38 brains. This averages to 1.2 clones per 
hemisphere, not including unlabeled brains (Figure 2.3). The efficiency of our labeling 
allows us to confidently identify clones in our MADM-labeled brains. 
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Figure 2.2 Overview of experimental procedure for MADM-based clonal analysis of 
neocortical gliogenesis. (A) Following coronal serial sectioning and IHC,individual 
brain sections are examined for MADM labeled cells and contoured based on DAPI 
signal. Consecutive sections are aligned based on contours. A single recovered clone is 
reconstructed. Brain Region is identified by matching the countoured sections to the 
Allen Brain Atlas. (B) Confocal images of consecutive sections of the clone shown in 
A.(C) Reconstructed clone from sections in B. Legend shows markers for cell types and 
laminae utilized throughout 3D reconstructions in this document. (SSCtx, 
somatosensory cortex; MOCtx, motor cortex). Scale bar 20 µm 
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Figure 2.3 Identification of clones using the MADM strategy. Example reconstructed 
brain and clone using MADM approach. (A) Shows confocal microscope images of a G2-
X clone composed of neurons and glia that spans multiple consecutive sections. (B) 3D-
reconstruction of clone in A. (C) Reconstructed MADM labeled brain with all green and 
red cells marked. An isolated cluster of clonally-related cells selected in dotted box. 
Large yellow structure corresponds to left lateral ventricle. Large blue structure 
represents outline of hippocampal layers. (D) Quantification of number of labeled of G2-
X MADM gliogenic clones per brain at late inductions E13-E16. (n = 38 brains, data 
presented as individual points per clone, bars indicate mean ± SEM. D, dorsal; V, 
ventral; M, medial; L, lateral; A, anterior; P, posterior.   
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2.4 Identification of glial subtypes by molecular and morphological criteria 
 Astrocytes and oligodendrocytes in the neocortex are readily distinguished by 
their characteristic morphologies, as validated by using established markers for these 
cell types (Figure 2.4, Figure 2.5). Molecularly, astrocytes are characterized by the 
expression of the intermediary filament protein GFAP (glial fibrillary acidic protein). 
The three recognized astrocytic subtypes differ in their characteristic morphologies. 
Protoplasmic astrocytes, which are found throughout the gray matter are characterized 
by a “bushy morphology”. They have 4-6 thick main branches that extend radially from 
the soma and the continue to branch off into gradually finer processes that occupy a 
large fraction of the volume that surrounds the cell body. Fibroblast-like astrocytes are 
found adjacent to the pia mater. Instead of radial processes, this astrocyte subtype has a 
flat structure that runs parallel to the pia matter (Figure 2.4, B’’). Fibrous astrocytes in 
the white matter, similar to protoplasmic astrocytes, exhibit several thick main branches 
that extend radially from the cell body accompanied by finer, but still relatively thick 
branches. We confirmed that these cells are in fact astrocytes by co-staining with GFAP 
(Figure 2.4). 
 
Oligodendrocyte subtypes exhibit a range of morphologies and molecular 
profiles that reflect the various intermediate stages towards their functional 
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differentiation from OPCs to fully differentiated myelinating oligodendrocytes. OPCs 
are characterized by a “lacy” morphology with several thin processes that extend 
radially from the soma. OPC radial processes differ from those of protoplasmic 
astrocytes because they do not occupy a large fraction of their surrounding volume, so 
they lack the “bushy” appearance. OPCs also lack the thick main branches characteristic 
of astrocytes. Another feature that distinguishes oligodendrocytes from astrocytes is the 
relatively smaller soma. OPCs are positive for the transcription factor Olig2 
(oligodendrocyte transcription factor) (Figure 2.5 D, D’). Immature oligodendrocytes 
combine features of OPCs and mature oligodendrocytes. The immature 
oligodendrocyte population is composed by several intermediate oligodendroglia 
subtypes that have committed to differentiation40. They have a combination of the fine 
radial processes of OPCs, and the thin processes that extend parallel to axonal tracts of 
myelinating oligodendrocytes. These cells are also positive for the transcription factor 
Olig2. Myelinating oligodendrocytes are more frequently found in the white matter and 
have processes that run parallel to axonal tracts. 
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Figure 2.4 Identification of Emx1-MADM labeled astrocytes. (A) and (C) show non-
consecutive sections in the same brain, cells belong to two separate clones. (B) and (D) 
are Z-projections of 20X confocal images of cells selected in A and C, respectively. 
(B’,B’’) and (D’,D’’) show Z-projections of 60X confocal images of the areas selected in B 
and D, respectively. XZ and YZ planes are shown along the axes.  
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Figure 2.5 Identification of Emx1-MADM labeled oligodendrocytes. (A) and (C) are 
consecutive sections with oligodendrocytes belonging to the same clone. Images are Z-
projections of 10X confocal images. (B) and (D) Are Z-projections of 20X confocal 
images of cells in A and C, respectively. (B’) and (D’) show 60X Z projections of the 
areas selected in B and D, respectively. XZ and YZ planes are shown along the axes. 
Scale bar, 20 µ
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2.5 Comparison of TM-mediated Cre-ER recombination via different administration 
routes 
In order to capture the final neurogenic divisions and entry into gliogenesis of 
RGPs, we performed TM induction at late embryonic stages E14, E15, and E16. At the 
earlier induction time points E10, E11, E12, and E13, TM was administered via 
intraperitoneal (IP) injection to pregnant dams. The maximum dose used at E10-E13 
was 50 µg/g body weight. However, when we attempted administer this dose via IP 
injection to dams at E14-E16, it resulted in miscarriages and embryo malformations that 
led to perinatal death (P0-P4). For this reason, we performed TM administration via oral 
gavage which led to increased embryo survival. This may be due to difference in the 
metabolism of TM that enters through the peritoneum or the gastrointestinal tract. With 
progression of embryonic time, TM dosages need to be increased in order to induce 
recombination in dividing progenitors. We believe this is due not only to an increase in 
embryo size, but also a reduced availability of dividing progenitors as they exit cell 
cycle. For E14-E16 inductions, the dosage was adjusted to a dose of 200-250 µg/g body 
weight via oral gavage. 
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We were concerned that different methods of TM administration may affect the 
onset of Cre-ER mediated recombination due to differences in metabolism between the 
different routes used. This may affect the window during which RGPs are labeled 
resulting in a temporal gap that may confound the comparison of data obtained from 
consecutive time points via different administration routes. If there is a significant 
difference in time of recombination by IP and oral gavage, we would expect a 
significant difference in clone sizes obtained through each method at the same time 
point. This difference would correspond to progenitors labeled earlier or for a more 
prolonged period via one route relative to the other. We compared clone size, as total 
number neurons per clone and as total glia per clone, in G2-X clones that contained a 
mixture of neurons and glia at E13 induced by IP administration and oral gavage. We 
found that administration of TM via different routes does not significantly affect clone 
size (Figure 2.6). This indicates that TM-mediated induction occurs with a similar delay 
upon administration by both methods.  
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Figure 2.6 Quantification of clone size of Emx1-MADM labeled clones composed of a 
mixture of neurons and glia. (A) Quantification of total neuron number per clone. (B) 
Quantification of total glia number per clone. All inductions were performed at E13. (IP, 
n = 16; oral gavage, n = 40). Data are presented as mean ± SEM. n.s., not significant.
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Chapter 3 
 
Gliogenesis in the neocortex at the individual radial glia 
progenitor level 
  
3.1 Late embryonic MADM labeled progenitors capture RGP entry into gliogenesis 
Previous published work from our lab showed that while a majority of RGPs exit 
cell cycle at the end of neurogenesis, a defined fraction of 16%, roughly 1 in 6 
progenitors, proceeds to gliogenesis. Although we recovered some clones composed of 
only glia, we focused our analysis of gliogenesis on the subset of clones that contain a 
mixture of neurons and glia (hereafter referred to as mixed clones). It is established that 
RGP neurogenesis precedes gliogenesis. Therefore, we expect that mixed clones capture 
the full gliogenic output of RGPs.  
 
Consistent with the progression of neurogenesis through embryonic 
development, we found a gradual decrease in neuron number in clones from E10-E16 
(Figure 3.1A). This corresponds to the diminishing potential of RGPs transition from 
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earlier rounds of symmetric division, where the pool of RGPs is expanded, to 
asymmetric division where they are restricted to produce either Tbr2-positive 
intermediate precursor cells, neurons, and/or glia. Our lab has established that the 
output of a single RGP is a “quantum” of 8-9 neurons83. Clones labeled at E10 to E12 
produce a number of neurons several multiples the size of the neurogenic quantum, 
corresponding to multiple RGPs in the labeled clone. RGPs labeled at later stages 
capture fewer of these symmetric divisions, resulting gradually smaller clones until E13, 
where the majority of clones undergo asymmetric division. This is consistent with our 
previously published work that finds clonal expansion by symmetric division is 
predominant at early developmental stages. Clones labeled at E13-E16 contained a 
clone size of neurons that averages below the unit size, which indicates we are labeling 
individual RGPs (Figure 3.1A, B). Clone size continues to decrease from E13 to E16 as 
RGP proliferative capacity is depleted through sequential rounds of division as they 
produce their final neurons.  
 
 Similarly, when we examine the gliogenic output of mixed G2-X clones, we find 
that from E10 to E11 there is a significantly larger number of glia labeled in each mixed 
clone (Figure 3.1C). This is consistent with symmetric expansion of RGPs which 
increases the probability of having more than one gliogenic RGP per clone. However, 
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we find a comparable number of total glia (astrocytes plus oligodendrocytes) labeled in 
clones from E13-E16 (Figure 3.1C, D). These stages correspond to asymmetrically 
dividing clones, where we are labeling an individual RGP. Because our glia number 
accounts for the combination of astrocytes and oligodendrocytes, we also quantified 
these glia types separately. We found, consistent with the result for total glia, a constant 
number of astrocytes and oligodendrocytes produced by progenitors labeled from E13 
to E16 (Figure 3.1E, F). These results indicate when we capture the asymmetric 
neurogenic phase of RGPs, we can capture their full gliogenic output. If this is true, we 
would predict that there is no correlation between neuronal output and glial output in 
asymmetric mixed clones. Our analysis revealed no correlation between total number of 
neurons and total number of glia in clones labeled at E13 to E16 (Figure 3.1G).  
 
Together these results suggest that there is a regulation in the number of glia 
produced by an individual RGP independent of when exit from neurogenesis occurs. A 
consistent distribution of clone sizes throughout these final neurogenic stages allows us 
to combine the data recovered from E13-E16 inductions for further analysis.   
 
One caveat of our method is that the total number of glia identified in our 
MADM-labeled clones may not be equal to the total number of glia that progenitor 
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produces: while it has been demonstrated that there is no extensive cell-death in the 
cortex in the excitatory neuron lineage, there is no conclusive evidence whether there is 
a postnatal period of glial pruning, where glial cells are removed.  
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Figure 3.1 Quantification of MADM neuron-glia clone size. (A) Quantification 
of total neuron number per mixed clone. (P21-P40: E10, n=12; E11, n =13; E12, n = 9; E13, 
n = 56; E14, n = 30; E15, n =20; E16, n =3). (B) Quantification of neuron number per 
mixed clone, from E13-E16 data shown in A. (C) Quantification of total glia number per 
mixed clone (sum of astrocytes and oligodendrocytes). (D) Only shows E13-E16 data in 
C. (E) Quantification of oligodendrocyte number per clone at E13-E15 inductions, for 
clones which contain oligodendrocytes. (F) Quantification of astrocyte number per 
clone at E13-E15 inductions, for clones which contain astrocytes. (G) Scatterplot of the 
size of clone glia number versus the size of the clone neuron number for individual 
mixed clones at E13-E16 inductions. A, B, data presented as mean ± SEM. B, D, E, F, 
points represent individual clones, bars indicate mean ± SEM. (*p < 0.05, **p< 0.01,***p < 
0.001, ****p < 0.0001)
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3.2 Three different types of gliogenic progenitors differ in their potential to produce 
glial subtypes 
Our analysis at single-RGP resolution uncovered three distinct clone types based 
on their capacity to make neurons, astrocytes, and/or oligodendrocytes. One type 
produces neurons and astrocytes, the second type produces neurons and 
oligodendrocytes and the third type produces neurons, astrocytes, and 
oligodendrocytes; we will refer to these types as N+A, N+O, and N+A+O, respectively 
(Figure 3.2A). That we uncovered clones that only have astrocytes or oligodendrocytes 
and clones that have both glial subtypes indicates that not all progenitors need undergo 
a sequence of making one glial subtype prior to making the other.  
 
We further wanted to compare tri-potent N+A+O progenitors with their bi-
potent N+A and N+O counterparts to examine if there was a difference in proliferative 
capacity associated with their potential to generate more cell types. Indeed, N+A+O 
clones produce on average twice as much glia than N+A and N+O progenitors (N+A+O, 
16.3 ± 2.0; N+A, 7.5 ± 0.7; N+O, 10.7 ± 3.2). However, when we compare output of 
individual cell types, we find no significant difference between the number of astrocytes 
of N+A+O clones and N+A clones (Figure 3.2C; N+A+O, 7.5 ± 0.7; N+A, 6.3 ± 0.7), nor in 
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the number of oligodendrocytes in N+A+O clones compared to N+O (Figure 3.2D; 
N+A+O, 10.0 ± 2.0; N+O 10.7 ± 3.2).  
Examination of individual N+A+O clones showed no correlation between the 
astrocyte and oligodendrocyte output. Together these data suggest that the determined 
output of glia for  NA+O, N+A, and N+O gliogenic RGPs is not the same amount. If 
there were a similar output for all gliogenic RGPs, in N+A+O clones making more than 
one subtype would result in a decreased output of the other; but we observe an overall 
increase in the number of glia produced in N+A+O RGPs compared to their N+A and 
N+O counterparts (Figure 3.2E). This also suggests that oligodendrocyte and astrocyte 
precursors that arise from a common RGP maintain their intrinsic proliferative 
potential.  
 
3.3 Distribution of RGP subtypes is similar across late embryonic time points and 
neocortical brain regions 
To examine whether there is a temporal gradient in specification of RGP 
subtypes, we examined the proportions of each mixed clone type in clones recovered 
from E13 to E15 inductions. We focused on these time points as they are our most 
sampled late embryonic time points. If a temporal gradient in RGP subtype 
specification exists, we would predict a shift in the proportion of different clone types, 
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with a gradual decrease of earlier-specified types and a concomitant increase in later-
specified clone types. Our data does not reveal a significant difference in the proportion 
of clone types across different induction time points. This suggests that a constant 
proportion of different clone types are specified from the same pool of progenitors, 
independent of the time they enter gliogenesis. The proportion and output of different 
RGP types are consistent throughout neocortical brain regions (Figure 3.3B). Together 
these data suggest that proportions of different progenitor types and their gliogenic 
capacity are a general property independent of cortical region. This is similar to our 
previously published data that shows that neurogenic output of clones is also similar 
across cortical regions83.  
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Figure 3.2 Three different mixed RGP subtypes based on their composition have 
distinct proliferative potential. (A) Shows 3D reconstructions of consecutive sections 
that contain MADM labeled clones with distinct potential: RGPs that generate neurons 
(solid color), astrocytes (light shades), and oligodendrocytes (dark shades), N+A+O; 
clones that generate neurons and oligodendrocytes, N+O, and clones that generate 
neurons and astrocytes, N+A. Laminar borders determined by DAPI staining are 
depicted as lines. (B) Quantification of total glia number per clone. (C) Quantification of 
astrocyte number per clone in N+A+O and N+A clones. (D) Quantification of 
oligodendrocyte number per clone in N+A+O and N+O clones. (E) Scatterplot of 
oligodendrocyte number versus astrocyte number per clone for N+A+O clones. 
Clones induced E13-E16; analyzed P21-P40: N+A+O, n = 21; N+A, n = 57; N+O, n = 15). 
B-D Individual clone sizes shown as points, bars show mean ± SEM. **p < 0.01; **** p < 
0.0001; n.s., not significant. 
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Figure 3.3 RGP subtype distribution is similar across developmental time points and 
brain regions.  (A) Percentage at N+A+O, N+A, and N+O mixed clones at E13, E14, E15 
inductions. (B) Percentage of different RGP types located in different neocortical areas. 
(C) Quantification of glial output of clones in different neocortical areas. (Medial, n = 12; 
MO, n = 18; SS, n = 22).  (D) Quantification of astrocytes production in clones in 
different neocortical areas. (Medial, n = 9; MO, n = 13; SS, n =19 ) (E) Quantification of 
oligodendrocyte number of clones located in different neocortical areas. (Medial, n = 6; 
MO, n = 6; SS, n = 8). SS, somatosensory cortex; MO, motor cortex; RSP, retrosplenial 
area; PTLp, posterior parietal association areas; VISal, visual cortex; AUD, auditory 
cortex; Medial includes: anterior cingulate area, infralimbic area, and prelimbic area. 
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3.4 Analysis of clone transitioning into gliogenesis uncovers different dynamics for 
RGP exit from neurogenesis  
 To further dissect the dynamics through which glia are specified from a single 
progenitor, we decided to focus on the cases where we recovered putative clones at the 
exit from neurogenesis We defined these as clones that have a single neuron 
accompanied by glia. Comparison of the fraction of single-neuron clones at different 
time points shows that a similar proportion of clones transition out of neurogenesis 
across the analyzed embryonic stages. This suggests a fixed rate at which RGPs, which 
represent a temporally uncoordinated population, exit neurogenesis and transition into 
gliogenesis through asymmetric division stages (Figure 3.4A). Most of the clones 
(57.9%) were composed of one daughter lineage composed of one neuron and the 
second daughter lineage composed purely of glia. This is the expected outcome for 
progenitors that proceed to produce glia after their final neurogenic division. However, 
we also uncovered two other cases of single neuron clones that do not correspond to a 
transition into gliogenesis. (1) clones where the neuron and the accompanying glia are 
all labeled in the same color (31.6%). These clones very likely arise from the first 
division where the daughter lineages are labeled, the daughter RGP in one lineage 
continues neurogenesis and proceeds to gliogenesis, while the labeled cell of the second 
lineage undergoes cell death. Recent studies indicate that there is reduction in the 
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number of neocortical excitatory neurons between P2 and P5, with the population 
dropping approximately 12% between these postnatal development stages, and then 
remaining stable into adulthood.84 (2) In a fraction of the cases, 10.5%, the neuron is 
labeled one color and the glia are labeled in both colors. It is likely this clone is the 
result of an initial division whereby the daughter lineages are labeled. One lineage 
specifies a glia-restricted precursor; while the RGP in the second daughter lineage self-
renews, produces the final neuron from neurogenesis, then proceeds to gliogenesis. 
This result suggests that gliogenesis may occur concurrently with neurogenesis from 
the same parent RGP. That is, the glia lineage of a progenitor may be produced while it 
is still in the neurogenic phase. This data differs from the established sequence of 
neurogenesis preceding gliogenesis. 
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Figure 3.4 Quantitative analysis of mixed clones transitioning from neurogenesis to 
gliogenesis reveals RGP behavior. (A) Percentage of single neuron clones recovered 
from E13 to E15 inductions. (B) Percentage of single neuron clones by composition and 
color of neuron and glia lineages. (C) Percentage of all G2-X mixed clones by color 
composition of their glia. (D) 3D reconstruction of a mixed single color clone. (E) 3D 
reconstruction of a mixed clone with glia in two colors. 
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3.5 Different dynamics underlie proliferation of astrocytes and oligodendrocytes  
 The frequency distributions of clone sizes for astrocytes and oligodendrocytes 
differ. About 10% of clones with astrocytes produce only 1 astrocyte. However, all 
clones containing oligodendrocytes produced ≥2 oligodendrocytes. This result is similar 
between N+A+O clones and their bi-potent counterparts (Figure 3.5, A, B), which 
suggests different mechanisms regulate the number of astrocytes and oligodendrocytes 
produced by individual RGPs. This finding further supports that astrocyte- and 
oligodendrocyte-restricted precursors derived from RGPs maintain their intrinsic 
properties when they are derived from a common (NAO) progenitor.  
 
Although our sampling is inconclusive, the dataset suggests a difference in 
distribution of astrocyte and oligodendrocyte clone sizes. When we examine the 
frequency distribution of different clone sizes, we find similar frequencies of clone sizes 
from 1-14 astrocytes, with a much smaller probability for larger clones. For 
oligodendrocytes, there seems to be a bimodal distribution, with one curve describing 
the probabilities of smaller clones 1-8 and another curve describing larger clone sizes 
13-24 (Figure 3.5C, D). Because the distribution of glia clone sizes are not randomly 
dispersed, but seems to be centered at different peaks, this suggests that gliogenesis is 
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not a stochastic event but that there is a constraint in the glial output of individual 
progenitors.  
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Figure 3.5 Quantitative analysis of astrogliogenesis and oligodendrogenesis. (A) 
Percentage of clones composed of a single astrocyte or n>1 astrocyte, by clone subtype. 
(B) Percentage of clones composed of a single oligodendrocyte or n>1 oligodendrocytes, 
by clone subtype. (C) Histogram of frequency distribution of clone sizes by astrocyte 
number. (D) Histogram of frequency distribution of clone sizes by oligodendrocyte 
number  
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3.6. Contrast in the distribution of RGP-derived astrocytes and oligodendrocytes 
 The following sections focus on the distribution of glia in a clone. In the 
neocortex, excitatory neuron cytoarchitecture reflects function, whereby neurons 
distributed through different lamina have differing properties but are similar to those 
within their layer, as explained in section 1.3. Astrocyte subtypes are partially 
distinguished by location, so lamina can be used as a proxy to gain insight on how 
subtype heterogeneity is established for neocortical glia.  
 
Most oligodendrocyte clones (77.8%) are clustered into a single layer (Figure 3D). 
These single layer clones are mostly found in layer 4 (Figure 3E). This is compared to 
astrocytes, where a smaller fraction (36%), are restricted to a single layer (Figure 3B). 
Astrocytes clones that span a single layer are mostly found in the white matter (Figure 
3C). Because white matter astrocytes are of the fibrous subtype, this result suggest that 
fibrous astrocytes have a diminished migratory and/or proliferative capacity compared 
to protoplasmic and ‘fibroblast-like’ astrocytes. We cannot conclude whether this is a 
property intrinsic of the cell type, or whether the WM is a less permissive environment 
for astrocyte proliferation compared to GM.  
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For clones where glia spans multiple layers, we see a wider spread in the 
distribution of astrocytes compared to that of oligodendrocytes (Figure 3.7 A, C). 
Oligodendrocyte clones are mostly distributed in deep cortical layers. If the clone is 
spread throughout multiple layers, it is mostly adjacent layers between Layer 5 and the 
white matter.  If we examine the total oligodendrocyte population recovered by MADM 
clonal labeling, we also find that most oligodendrocytes are destined for deep cortical 
layers (layers 5-6) and the white matter, with 59.2% and 18.5% of oligodendrocytes, 
respectively (Figure 3.7 D). A smaller fraction, 9.3% of oligodendrocytes are destined 
for the superficial cortical layers 2-4, and only 3.1% of oligodendrocytes are destined for 
pia-Layer 1. This contrasts with the distribution of astrocytes where 41.1% of total 
recovered astrocytes are destined for layers spanning the pial surface to layer 4. 
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Figure 3.6 Laminar locations of clones that span a single cortical layer. (A) 3D 
reconstrcuted clones show representative cellular distributions in different clone types. 
(B) Fraction of mixed clones where astrocytes are restricted to one layer. (C) Laminar 
location of single-layer astrocytes. (C) Fraction of mixed clones where oligodendrocytes 
are restricted to one layer. (D) Laminar location of single-layer oligodendrocytes.  
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Figure 3.7 Laminar distribution of glia generated by mixed neuron/glia clones. (A) 3D 
reconstructions of mixed clones containing astrocytes and oligodendrocytes. Lamina are 
indicated with colored lines, following borders shown by DAPI signal. (B) Laminar 
distribution of oligodendrocytes in mixed clones containing oligodendrocytes. (C) 
Laminar distribution of all oligodendrocytes recovered in mixed clones. (D) Laminar 
distribution of astrocytes in mixed clones containing astrocytes. (E) Laminar 
distribution of all astrocytes recovered in mixed clones. For N+A+O clones, astrocyte 
and oligodendrocyte lineages were examined separately.  
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Chapter 4 
Discussion and Future Directions 
 
4.1 Clonal analysis of RGPs reveals several aspects of how cortical gliogenesis is 
regulated at the individual progenitor level  
Proper neural function relies on the regulation of the number and proportion of 
neuronal and non-neuronal cell types. To understand how individual progenitor 
behavior is regulated to establish the correct numbers, subtypes, and arrangements of 
the glial population, we performed clonal analysis of neocortical RGPs at their 
transition from neurogenesis into gliogenesis. Our work is the first to examine lineage 
relationships between the three major neural cell types – neurons, astrocytes, and 
oligodendrocytes. Further, our work is the first to trace gliogenic RGPs in a progenitor 
domain and time-specific manner. This work is the first to examine gliogenesis at the 
individual progenitor resolution which such specificity and resolution. 
 
To summarize our key findings: after neocortical RGPs enter the asymmetric 
neurogenic division stage, around E13, we found that glial output is not correlated with 
embryonic induction time nor neuron output. This result suggests that the regulation of 
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glia number is independent of when exit from neurogenesis occurs. We found three 
different RGP types based on their potential to make neurons, astrocytes, and/or 
oligodendrocytes. These subtypes are equally distributed throughout late embryonic 
induction timepoints and neocortical brain regions, suggesting a general mechanism for 
determining RGP subtype. We found a tripotent progenitor (N+A+O) capable of making 
twice the glia of their bipotent counterparts (N+A, N+O). Our results also suggest a 
fixed rate at which RGPs, which represent a temporally uncoordinated population, exit 
neurogenesis and transition into gliogenesis.  
 
We found that Emx1-RGP oligodendrogenesis contrasts with astrogliogenesis in 
several aspects. Consistent with previously published data based on tracing Thy1.2-Cre 
progenitors79, a promoter that labels RGPs nonspecifically, we found that Emx1 RGP-
derived astrocytes account for most of the neocortical astrocytes. However, our data 
suggests that at least 30% of oligodendrocytes emerge from a different progenitor 
domain. The decline of the Emx1-derived oligodendrocyte population has been 
reported62. We found that OPCs have a higher proliferative capacity than astrocyte-
restricted precursors. Finally, our results were the first to analyze at the clonal level 
RGP-derived glia are allocated to the cortex – possibly providing insight into 
developmental sources of glial heterogeneity. We found that the majority of 
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oligodendrocytes are clustered to one layer while astrocytes can span the full cortical 
width. Our data suggest separate lineages for Layer-1 and WM astrocytes, and suggests 
an inside-out allocation of astrocytes. Most oligodendrocytes are destined for deep 
cortical layers (5-6) and WM whereas 40% of astrocytes are destined for superficial 
layers (1-4). Further work, where population analysis and stereology is performed on 
the Emx1-derived glial population can reveal whether our findings at the individual 
progenitor level correspond to the number and distribution of astrocytes and 
oligodendrocytes throughout the neocortex. 
 
The conclusions from this analysis point towards the importance of cell-intrinsic 
regulation in gliogenesis. We found a constant number of glia produced by progenitors 
labeled from E13 to E16, after most RGPs have entered asymmetric division. In these 
clones, we found no correlation between neuronal and glial output. These results 
indicate when we capture neurogenic phase of RGPs we can capture their full gliogenic 
potential. This is in accordance the established sequence that gliogenesis precedes 
neurogenesis in RGPs. Further, these data suggest that there is a regulation in the 
number of glia produced by an individual RGP independent from when exit from 
neurogenesis occurs. The proportion and glial output of different RGP types are 
consistent throughout neocortical brain regions and induction time points. This 
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suggests specification of RGP subtypes is independent of developmental stage and 
location along the anterior-posterior axis, but is a general property.  
 
Glial output is also independent of developmental time and neocortical region, 
which also points toward the importance of a cell-intrinsic mechanism in the 
determination of glial output. Extracellular signal availability varies according to brain 
region and developmental time. Morphogens such as Shh and BMP, which have been 
demonstrated to impact gliogenesis have a temporal and regional gradient85. In 
addition, extracellular cues such as cytokines that are available vary through 
developmental time as the nascent cortical plate is invaded by newly born neurons86. 
Further, we see that the oligodendrocyte and astrocyte output of glial progenitors are 
not a factor of the progenitor’s potential to produce different cell types. 
 
MADM-based clonal analysis of neocortical gliogenesis uncovered three distinct 
clone types based on their capacity to make neurons (N), astrocytes (A), and/or 
oligodendrocytes (O); based on their composition, these types are N+A, N+O, and 
N+A+O. That we uncovered clones that only have astrocytes or oligodendrocytes and 
clones that have both glial subtypes indicates that not all progenitors need to undergo a 
sequence of making one glial subtype prior to making the other, but may be restricted 
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to producing one type of glia. Had their been common gliogenic sequence for all 
progenitors we would expect to uncover either N+O and N+A+O clones, while clones 
containing astrocytes are devoid of neurons; or N+A clones and N+A+O clones, with 
oligodendrocyte clones. Tri-potent (N+A+O) progenitors produce on average twice as 
much glia but the same number of individual glial types compared to their bi-potent 
(N+A, N+O) counterparts. We found no correlation between the astrocyte and 
oligodendrocyte output of N+A+O clones. This suggests that oligodendrocyte and 
astrocyte precursors that arise from an individual RGP maintain their intrinsic 
proliferative potential. The increased proliferation potential and ability to produce cell 
types in N+A+O clones may suggest that the increased capacity to specify cell types is a 
factor of increased duration in cell cycle. Analysis of MADM labeled clones at early 
postnatal stages, where gliogenesis largely occurs, would increase our resolution into 
how glia clones are established. Combining the data of developing clones with our data 
of mature clones in the adult brain will offer snapshots to help decipher the sequence of 
gliogenesis and distribution of glial cells. 
 
Comparison of the fraction of single-neuron gliogenic clones at different time 
point shows that a similar proportion of clones transition out of neurogenesis across the 
analyzed late embryonic stages (E13-E15). This suggests a fixed rate at which RGPs, 
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which represent a temporally uncoordinated population, exit neurogenesis and 
transition into gliogenesis. Most gliogenic RGPs proceed to produce glia after a final 
neurogenic division, however we found two special cases:  
(1) RGPs produce a glial precursor and continue to produce neurons before 
entering gliogenesis. This result suggests that gliogenesis may occur concurrently with 
neurogenesis from the same parent RGP. That is, there is not a molecular on/off switch 
that occurs at the start of gliogenesis, but a program that can also lead to the production 
of neurons. 
 (2) One of the daughter cells of the RGP is lost, while the RGP continues to 
produce cells. This result will be discussed more in depth in section 6.2.  
 
Analysis of differentiation potential in single neuron gliogenic clones shows that 
the majority of RGPs (63.2%) produce neurons and astrocytes, approximately one third 
make all three cell types (26.3 %), and 1 in 10 (10.5%) are restricted to the production of 
neurons and oligodendrocytes. We can combine our quantitative results to estimate the 
proportion of neurons and glia in the neocortex: 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛	𝑔𝑙𝑖𝑜𝑔𝑒𝑛𝑖𝑐	𝑅𝐺𝑃𝑠 ∗ ( 𝐴𝑣𝑔.𝑁	𝐴𝑠𝑡𝑟𝑜𝑐𝑦𝑡𝑒𝑠 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛	𝑎𝑠𝑡𝑟𝑜𝑔𝑒𝑛𝑖𝑐	𝑅𝐺𝑃𝑠 +(𝐴𝑣𝑔.𝑁	𝑜𝑙𝑖𝑔𝑜𝑑𝑒𝑛𝑑𝑟𝑜𝑐𝑦𝑡𝑒𝑠)(𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛	𝑜𝑙𝑖𝑔𝑜𝑑𝑒𝑛𝑑𝑟𝑜𝑔𝑒𝑛𝑖𝑐	𝑅𝐺𝑃𝑠))𝑅𝐺𝑃	𝑛𝑒𝑢𝑟𝑜𝑛	𝑢𝑛𝑖𝑡𝑎𝑟𝑦	𝑜𝑢𝑡𝑝𝑢𝑡  
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Where the fraction of gliogenic RGPs is 1/6, average number of astrocytes is 7.2, 
fraction astrogenic RGPs is 89.5/100, average number of oligodendrocytes is 10.3, and 
the fraction of oligodendrogenic clones is 36.8/100.  
 
 We find that the overall ratio of glia to neurons is 1:5. Our glia:neuron ratio is 
much lower than the estimated 56.2% of non-neuronal cells in the mouse cortex 
(Herculano-Houzel 2006). This result suggests that roughly 30% of neocortical glia are 
derived from a source other than Emx1+ progenitors, which are the exclusive source of 
neocortical pyramidal neurons. These additional glia could possibly arise from a pool of 
glia-restricted precursors in the dorsal VZ/SVZ, or migration of cells from other 
developmental niches. The astrocyte to neuron ratio calculated by the above formula is 
1:7.7. This ratio is similar to previously published estimates, where the ratio in lineage-
traced neocortical columns was 1:7.4. Similarly, they found a 1:8.4 S100B+/NeuN ratio 
across the gray matter. This suggests that most neocortical astrocytes arise from Emx1+ 
progenitors. 
 
The oligodendrocyte:neuron ratio based on our clonal analysis data is 1:14.2. 
Estimates of oligodendrocyte number is the cortex are unavailable, however data 
collected through our method can only be an underestimate of oligodendrocytes in the 
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neocortex. Fate mapping experiments have estimated that by adult stages the 
contribution to cortical oligodendrocytes from Emx1+ progenitors falls from 70% at 
early postnatal stages to 30%. This indicates that the oligodendrocyte population comes 
in large part from sources other than neocortical RGPs. 
 
The frequency distributions of clone sizes for astrocytes and oligodendrocytes 
differ. About 10% of clones with astrocytes produce only one astrocyte. However, all 
clones containing oligodendrocytes produced 2 or more oligodendrocytes. When we 
examine the frequency distribution of different clone sizes, we find similar frequencies 
of clone sizes, with a much smaller probability for larger clones. For oligodendrocytes, 
there seems to be a bimodal distribution, with one curve describing the probabilities of 
smaller clones 1-8 and another curve describing larger clone sizes 13-24. These data 
suggest different programs regulate the proliferation of astrocyte-restricted and 
oligodendrocyte-restricted glial precursors. Because OPCs remain proliferative through 
adulthood, it is possible that larger oligodendrocyte clone sizes are a product of 
progenitors that divide throughout the animal’s lifespan, or whether this is directly a 
product of late embryonic/early postnatal development. It would be interesting to 
examine how clone size and distribution is established through developmental 
timepoints, from the onset of gliogenesis (~E16) to adulthood, by performing clonal 
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analysis with endpoints through the animal’s life and comparing data acquired from 
different endpoints. 
 
Most oligodendrocyte clones (77.8%) are clustered into a single lamina. These 
single layer clones are mostly found in layer 6. This is compared to astrocytes, where a 
smaller fraction (36%), are restricted to a single layer. Astrocytes clones that span a 
single layer are mostly found in the white matter. Because white matter astrocytes are of 
the fibrous subtype, this result suggest that fibrous astrocytes have a diminished 
proliferative capacity compared to protoplasmic and ‘fibroblast-like’ astrocytes.  
For clones where glia spans multiple layers, we see a wider spread in the distribution of 
astrocytes compared to that of oligodendrocytes Oligodendrocyte clones are mostly 
distributed in deep cortical layers and white matter. This contrasts with the distribution 
of astrocytes where 41.1% of total recovered astrocytes are destined for layers spanning 
the pial surface to layer 4. Together these results are consistent with an even 
distribution of astrocytes throughout the neocortical parenchyma, in contrast with a 
higher concentration of oligodendrocytes in deep cortical layers and white matter. 
 
4.2 Effects of postnatal experience in neocortical gliogenesis 
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Although there is limited neurogenesis at postnatal ages, the glial population 
reaches its proliferation peak postnatally and continues into adult stages. This postnatal 
plasticity is amenable to the experience of the animal. It has been demonstrated that 
interventions such as environmental enrichment and motor learning may promote 
gliogenesis in task-specific regions such as mPFC, cingulate cortex, motor cortex, and 
visual cortex87. It has been demonstrated in human that skill learning can increase white 
matter regions88.  
 
Environmental enrichment protocols vary but include the introduction of novel 
toys, tunnels, food, and running wheel into grouped housed rodent cages. This leads to 
increased motor and cognitive activity and in turn, increased proliferation of 
oligodendrocytes. This proliferation may be mediated through increased neural activity 
as it has been demonstrated that stimulation of neurons promotes oligodendrogenesis 
and increases myelination in a circuit-specific manner36.  
 
Negative events may also shape cortical architecture. Stress, through either 
maternal stress or social isolation is thought to negatively affect oligodendrogenesis. 
This may be mediated by an increased release of stress-response hormones such as 
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corticosterone. Corticosteroids have shown to decrease OPC proliferation and myelin 
production89.  
 
By performing clonal analysis in animals housed under different conditions such 
as an enriched environment or social isolation, we can determine at the individual RGP 
level how proliferation is regulated in response to postnatal experience. How is clone 
size affected? Are certain RGP subtypes more susceptible to proliferate? Which glial 
lineages are affected? This research has important implications for future 
developmental studies. It may contribute to the body of work that demonstrates that 
animal conditions, such as maternal behavior, social interactions, environment may 
confound research.  
 
4.3 Contribution of cell death in shaping neocortical cell population 
Development and maintenance of the cell population in a tissue is a balance 
between the generation of new cells and the removal of unnecessary cells. During 
nervous tissue development, transient cell populations are lost as they exit cell cycle. 
Oligodendrocytes that invade the neocortex, during the first wave of 
oligodendrogenesis, invade the cortex form the ventral progenitor domain of Nkx2.1 
progenitors. Nkx2.1-derived neocortical oligodendrocytes are removed through 
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caspase-3 dependent cell death by the time the two subsequent waves of 
oligodendrocytes populate the neocortex, derived from Dlx2 and Emx1 domains.  
 
Cell death also occurs in the neuronal lineage. About 40% of developing 
interneuron population in the cortex is also removed through apoptosis90. Interneuron 
death is mediated by Bax (Bcl-2 asssociated X) – dependent apoptosis in postnatal 
stages. In Bax mutants, cell death of GAD67-GFP interneurons was nearly absent91. Bax 
is a protein that mediates cell death by inserting itself in the mitochondria in response 
to a variety of stress signals. In response to signaling, Bax changes conformation and 
becomes a pore-forming protein which induces apoptosis through release of 
cytochrome C and other mitochondrial proteins into the cytosol. Recent studies indicate 
that there is reduction in the number of neocortical excitatory neurons between P2 and 
P5, with the population dropping approximately 12% between these postnatal 
development stages, and then remaining stable into adulthood.84 
 
How does apoptosis help sculpt the development of the cortical cell population? 
One caveat of our clonal analysis is that the total number of glia recovered in our 
MADM-labeled clones may not be equal to the total number of glia that a labeled 
progenitor produces. About 30% of clones were composed of neurons and the glia in 
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one color. This strongly suggests, that at the time of mitosis where the parent RGP was 
labeled, the second daughter lineage underwent cell death.  
 
Clonal and population resolution studies can help elucidate the contribution of 
cell death in the neocortex. Bax mutation has been linked to developmental apoptosis in 
the neocortex. However, the contribution of Bax-mediated cell death in the Emx-1 glial 
lineage has not been directly examined. To analyze the role of Bax-mediated cell death 
in shaping the neocortical cell population, we may quantify and compare the number of 
pyramidal neurons, astrocytes, and oligodendrocytes in wild type, heterozygous, and 
Bax mutant animals. Emx1-derived cells can be distinguished from the general 
population by lineage tracing Emx1 progenitors with a Cre-driven by the Emx1 
promoter combined with a loxP flanked allele of a fluorescent protein such as eGFP. To 
examine the effect of Bax deletion on individual RGPs, clonal analysis can be performed 
by combining the Emx1-MADM system with a Bax mutant background. Bax can be 
bred into the Emx1-MADM-TG animals and the Emx1-MADM-GT allele to generate 
Emx1-MADM-TG/GT Bax-/-. Clone size and composition can be compared between 
mutant animals and their Bax heterozygous littermates.  
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Chapter 5 
Methods & Materials  
 
5.1 Animals and clonal induction 
MADM-11GT (JAX Stock No. 013749) and MADM-11TG (JAX Stock No. 013751) mice 
were produced as previously described82. Emx1-CreERT2 mice were kindly provided by 
Dr. Nicoletta Tekki-Kessaris. Mice were bred and maintained according to guidelines 
established by the Institutional Animal Care and Use Committee of Memorial Sloan 
Kettering Cancer Center. For MADM labeling, Emx1-CreERT2+/-; MADM-11GT/GT mice 
were crossed with MADM-11TG/TG mice and the time of pregnancy was determined by 
the presence of the vaginal plug (E0, ~noon). For clone induction, pregnant females 
were injected intraperitoneally with TM (T5648, Sigma) dissolved in corn oil (C8267, 
Sigma) at E10, E11, E12 and E13 at a dose of 5-25 µg/g body weight; or orally gavaged 
with TM at E13, E14, E15, and E16 at a dose of 150-300 µg/g body weight.   
 
5.2 Tissue processing  
Both male and female mice were perfused intracardially with 4% 
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paraformaldehyde (PFA) in phosphate-buffered saline (PBS, pH 7.4). Brains were 
removed and post-fixed overnight at 4°C. Serial coronal sections of individual brains 
were prepared using a vibratome (Leica Microsystems). Tissue was serially sectioned 
into 70-100 µm sections. Thicker sections resulted in us capturing more complete 
morphologies of cells in individual sections compared to thinner sections. We enhanced 
the intrinsic signal of the expressed GFP and RFP via immunohistochemistry, using 
antibodies specific to each protein. The sections were mounted onto slides for analysis. 
 
The following primary antibodies were used: chicken anti-GFP (1:1,000 dilution, 
GFP-1020, Aves Lab), rabbit anti-RFP (1:1,000 dilution, 600-401-379, Rockland), guinea 
pig anti-RFP (1:10,000 dilution, produced by the Songhai Shi lab), goat anti-GFAP 
(1:200, ab53554, Abcam), and rabbit anti-Olig2 (1:500, AB9610, Millipore). For GFAP, 
antigen retrieval was performed in brains fixed 6.5 hr in 4% PFA & followed by 
incubation in sodium citrate buffer (pH 6.0) at 80°C for 30 min.  Sections were mounted 
on glass slides, imaged using confocal microscopy (FV1000, Olympus or LSM700, Zeiss) 
and slide scanner (NanoZoomer 2.0-HT, Hamamatsu Photonics). 
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5.3 3D reconstruction 
Full brain scans were performed by either optical detection in an epifluorescent 
microscope or by scanning entire brains using Nanozoomer. Sections were 
reconstructed by manual tracing of outer borders using Neurolucida (MBF Bioscience). 
Neurons, astrocytes, and oligodendrocytes were distinguished based on their 
morphology and marker expression (See Section 2.4). Cells were represented as colored 
symbols (3-4 times the size of the cell body). Layer boundaries based on nuclear 
staining were also documented. Laminar boundaries were traced based on DAPI 
nuclear staining. To annotate brain regions, landmarks such as the lateral ventricles and 
the hippocampus were traced and used to identify location along the anterior-posterior 
axis based on the Allen Brain Atlas (http://mouse.brain-map.org/static/atlas). 
Consecutive brain sections were aligned manually based on outer boundaries, laminar, 
and landmark outlines.  
 
5.4 Statistics  
Statistical methods were used to predetermine sample sizes. Data collection and 
analysis were not randomized nor performed blind to the conditions of the 
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experiments. Data points were selected based on labeling (G2-X clones, green/red color) 
and composition (combination of neurons and glia). Data are mean ± S.E.M., and 
statistical differences between two groups were determined using non-parametric 
Mann–Whitney tests, which assume a non-Gaussian distribution. Chi-square tests were 
used to compare proportions between groups in contingency analyses. Linear 
regression analysis was performed to test for correlation between two parameters on X-
Y plots. Data distribution was not formally tested. Statistical significance was set at 
p<0.05. Exact p-values are provided in the figure legends. 
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